 |
|
Consequences of Asymptomatic Bacteriuria in Women With Diabetes Mellitus
Suzanne E. Geerlings, MD, PhD;
Ronald P. Stolk, MD, PhD;
Marielle J. L. Camps, MD;
Patrick M. Netten, MD, PhD;
J. Theo Collet, MD;
Peter M. Schneeberger, MD, PhD;
Andy I. M. Hoepelman, MD, PhD
Arch Intern Med. 2001;161:1421-1427.
Background Women with diabetes mellitus (DM) have asymptomatic bacteriuria (ASB)
more often than women without DM. It is unknown, however, what the consequences
of ASB are in these women.
Objective To compare women with DM with and without ASB for the development of
symptomatic urinary tract infections (UTIs), renal function, and secondary
complications of DM during an 18-month follow-up period.
Methods In this multicenter study we monitored women with DM with and without
ASB for the development of symptomatic UTIs, renal function, and secondary
complications (ie, retinopathy, neuropathy, microvascular, or macrovascular
diseases). Data on the first 18-month follow-up period are presented.
Results At least 1 uncontaminated urine culture was available from 636 women
(258 with type 1 DM and 378 with type 2 DM). The prevalence of ASB at baseline
was 26% (21% for those with type 1 DM and 29% for those with type 2 DM). Follow-up
results were available for 589 (93%) of the 636 women. Of these 589 women,
115 (20%) (14% with type 1 DM and 23% with type 2 DM) developed a symptomatic
UTI. Women with type 2 DM and ASB at baseline had an increased risk of developing
a UTI during the 18-month follow-up (19% without ASB vs 34% with ASB, P = .006). In contrast, there was no difference in the
incidence of symptomatic UTI between women with type 1 DM and ASB and those
without ASB (12% with ASB vs 15% without ASB). However, women with type 1
DM and ASB had a tendency to have a faster decline in renal function than
those without ASB (relative increase in serum creatinine level 4.6% vs 1.5%, P = 0.2).
Conclusion Women with type 2 DM and ASB have an increased risk of developing a
symptomatic UTI than those without ASB.
From the Department of Internal Medicine (Drs Geerlings, Collet, and
Hoepelman), Division of Infectious Diseases and AIDS (Drs Geerlings and Hoepelman),
the Julius Center for Patient Oriented Research (Dr Stolk), and the Eijkman
Winkler Laboratory for Medical Microbiology (Dr Hoepelman), University Hospital,
Utrecht; Department of Internal Medicine, Catharina Hospital, Eindhoven (Dr
Camps); Department of Internal Medicine (Dr Netten) and the Laboratory of
Medical Microbiology (Dr Schneeberger), Bosch Medicentrum's Hertogenbosch,
the Netherlands.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Differences in the Pattern of Antibiotic Prescription Profile and Recurrence Rate for Possible Urinary Tract Infections in Women With and Without Diabetes
Schneeberger et al.
Diabetes Care 2008;31:1380-1385.
ABSTRACT
| FULL TEXT
Asymptomatic Bacteriuria in Women With Diabetes Mellitus: Effect on Renal Function After 6 Years of Follow-up.
Meiland et al.
Arch Intern Med 2006;166:2222-2227.
ABSTRACT
| FULL TEXT
Urologic Complications of Diabetes
Brown et al.
Diabetes Care 2005;28:177-185.
FULL TEXT
Management of Asymptomatic Bacteriuria in Patients with Diabetes Mellitus
Ooi et al.
The Annals of Pharmacotherapy 2004;38:490-493.
ABSTRACT
| FULL TEXT
Asymptomatic Bacteriuria and Leukocyturia in Type 1 Diabetic Children and Young Adults
Rozsai et al.
Diabetes Care 2003;26:2209-2210.
FULL TEXT
Treatment of Asymptomatic Bacteriuria in Diabetic Women
Geerlings et al.
NEJM 2003;348:957-958.
FULL TEXT
Antimicrobial Treatment in Diabetic Women with Asymptomatic Bacteriuria
Harding et al.
NEJM 2002;347:1576-1583.
ABSTRACT
| FULL TEXT
Adherence of Type 1-Fimbriated Escherichia coli to Uroepithelial Cells: More in diabetic women than in control subjects
Geerlings et al.
Diabetes Care 2002;25:1405-1409.
ABSTRACT
| FULL TEXT
|
